Abstract
A prodrome is a premonitory set of signs and symptoms indicating the onset of a disease. Prodromes are frequently reported by hereditary angioedema (HAE) patients, antedating attacks by a few hours or even longer. In some studies, high incidence of prodromes was reported by patients, with considerable number being able to predict oncoming attacks. Regrettably, prodromes have never received a consensual definition and have not been properly investigated in a systematic fashion. Therefore, their nature remains elusive and their contribution to the diagnosis and treatment of disorders is uncertain. The term “prodrome,” as used in various pathologies, denotes different meanings, timing, and duration, so it may not be equally suitable for all clinical situations. Perception of a prodrome is unique for each individual patient depending on self-experience. As modern drugs delegate the administration decision to the patients, early detection of a developing attack may help mitigate its severity and allow deployment of appropriate therapy. New diagnostic instruments were recently developed that can assist in defining the attributes of prodromes and their association with attacks. We will review the prodrome phenomenon as exhibited in certain clinical situations, with an emphasis on prodromes of HAE.
Similar content being viewed by others
Data Availability
Iris Leibovich Nassi RN, PhD thesis (Tel Aviv University).
Abbreviations
- AngPT:
-
Angiopoietin
- BK:
-
Bradykinin
- BKR:
-
Bradykinin receptor
- C1-INH:
-
C1 Inhibitor
- CGRP:
-
Calcitonin gene-related peptide
- C4:
-
Complement component 4
- EM:
-
Erythema marginatum
- FMF:
-
Familial Mediterranean fever
- GI:
-
Gastrointestinal
- HAE:
-
Hereditary angioedema
- HZV:
-
Herpes zoster virus
- KKS:
-
Kallikrein-kinin system
- NKA:
-
Neurokinin A
- NOS:
-
Nitrous oxide species
- PLA:
-
Phospholipid A
- PRO:
-
Patient reported outcome
- SP:
-
Substance P
- TRP:
-
Transient receptor potential
- VEGF:
-
Vascular endothelial growth factor
References
Osler W (1888) Hereditary angio-neurotic oedema. Am J Med Sci 95:362–367. https://doi.org/10.1097/MAJ.0b013e3181b2803f
Kemp JG, Craig TJ (2009) Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review. Allergy Ast Proc 30:493–499
Reshef A, Kidon M, Leibovich I (2016) The story of angioedema: from Quincke to bradykinin. Clin Rev Allergy Immunol 51(2):121–139. https://doi.org/10.1007/s12016-016-8553-8
Prematta MJ, Kemp JG, Gibbs JG, Craig TJ (2009) Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. Allergy Ast Proc 30:506–511
Prematta MJ, Bewtra AK, Levy RJ, Wasserman RL, Jacobson KW, Machnig T et al (2012) Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacks. Adv Ther 29(10):913–922. https://doi.org/10.1007/s12325-012-0053-5
Reshef A, Prematta M, Craig TJ (2013) Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys. Allergy Ast Proc 34(3):261–266
Strauss AL, Glaser BG (1975) Chronic illness and the quality of life (2nd Edition). Saint-Louis MO: CV Mosby; pp160. ISBN-10: 0801648378
Prodrome, (2020) Wikipedia http://en.wikipedia.org/wiki/Prodrome. Accessed 22 November 2020
Prodrome, (2020) Merriam-Webster Dictionary online. https://www.merriam-webster.com/dictionary/prodrome. Accessed 22 November 2020
Prodrome, (2020) The free Dictionary. https://medical-dictionary.thefreedictionary.com/prodrome. Accessed 22 November 2020
Cheung T, Mossbridge JA (2018) The premonition code: the science of precognition. Watkins Publications, London, England
Mossbridge JA, Radin D (2018) Precognition as a form of prospection: a review of the evidence. Psychology of consciousness: Theory, Research and Practice 5(1):110–116
Peng KP, May A (2020) Redefining migraine phases—a suggestion based on clinical, physiological, and functional imaging evidence. Cephalagia. Jan 13 10.1177%2F0333102419898868
Blau JN (1980) Migraine prodromes separated from the aura: complete migraine. Br Med J 281:658–660
Amery WK, Waelkens J, Vandenbergh V (1986) Migraine warnings. Headache 26:60–66
Kelman L (2004) The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 44(9):865–872
Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD (2006) The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia 26:1209–1213
Houtveen JH, Sorbi MJ (2013) Prodromal functioning of migraine patients relative to their interictal state—an ecological momentary assessment study. PLoS ONE 8(8):e72827. https://doi.org/10.1371/journal.pone.0072827
Santoro G, Bernasconi F, Sessa F, Venco A (1990) Premonitory symptoms in migraine without aura: a clinical investigation. Funct Neurol 5:339–344
Rasmussen BK, Olesen J (1992) Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 12:221–228
Silberstein SD, Young WB (1995) Migraine aura and prodrome. Semin Neurol 15:175–182
Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J et al (2003) Premonitory symptoms in migraine: an electronic diary study. Neurol 60:935–940
Tandon SJ, Keshavan MS et al (2012) Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. Neuropsychiatry 2(4):345–353
Kelleher I, Murtagh A, Molloy C, Roddy S, Clarke MC, Harley M et al (2012) Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizoph Bull 38:239–246
Howes OD, Fusar-Poli P, Bloomfield M, Selvaraj S, McGuire P (2012) From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments. Curr Pharm Design 18(4):459–465. https://doi.org/10.2174/138161212799316217
Yung AR, McGorry PD (1996) The initial prodrome in psychosis: descriptive and qualitative aspects. Aus NZ J Psych 30:587–589
Mikanmaa E, Grent-’t-Jong T, Hua L, Recasens M, Thune H, Uhlhaas PJ (2017) Towards a neurodynamical understanding of the prodrome in schizophrenia. Neuroimage S1053–8119 https://doi.org/10.1016/j.neuroimage.2017.11.026
Emsley R (2013) Non-adherence and its consequences: understanding the nature of relapse. World Psych 12(3):234–235
Straus SE, Ostrove JMIn chauspe G, Straus SE, Ostrove JM, Inchauspé G, et al (1988) NIH conference: Varicella zoster infections. Biology, natural history, treatment and prevention. Ann Int Med 108:221–237
Chappell JD, Dermody TS (2010) Introduction to viruses and viral diseases. In: Mandell, Douglas & Bennett’s Principles of infectious diseases, 7th edition, Philadelphia, Churchill Livingstone-Elsevier. pp:1907–1922
Zerngast WW, Paauw DS, O’Connor KM (2013) Varicella Zoster with extended prodrome: a case series. Am J Medicine 126:359–361
Ben-Chetrit E, Touitou I (2009) Familial Mediterranean fever in the world. Arth Rheum 61:1447–1453. https://doi.org/10.1002/art.24458
Touitou I (2001) The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Gen 9:473–483
Lidar M, Yaqubov M, Zaks N, Ben Horin S, Langevitz P, Livneh A (2006) The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 33(6):1089–1092
Babaoglu H, Varan O, Kucuk H, Atas N, Satis H, Salman R et al (2019) On demand use of anakinra for attacks of familial Mediterranean fever (FMF). Clin Rheumatol 38(2):577–581
Amoura Z, Papo T, Ninet J, Hatron PY, Guillaumie J, Piette AM et al (1997) Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J of Med 103:514–519
Druey KM, Greipp PR (2010) Narrative review: the systemic capillary leak syndrome. Ann Int Med 153:90–98
Pineton de Chambrun M, Luyt CE, Beloncle F, Gousseff M, Mauhin W, Laurent Argaud L et al (2017) The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission. Crit Care J 45(7):1216–1223
Druey KM, Parikh SM (2017) Idiopathic clinical picture of severe systemic capillary-leak syndrome episodes requiring (Clarkson disease). J Allergy Clin Immunol 140(3):663–670. https://doi.org/10.1016/j.jaci.2016.10.042
Wijnands JM, Zhu F, Kingwell E, Zhao Y, Ekuma O, Lu X et al (2019) Five years before multiple sclerosis onset: phenotyping the prodrome. Mult Scl 25(8):1092–1101. https://doi.org/10.1177/1352458518783662
O’Keefe-McCarthy S, Ready L (2016) Impact of prodromal symptoms on future adverse cardiac-related events: a systematic review. J Cardiovasc Nurs 31(1):1–10. https://doi.org/10.1097/JCN.0000000000000207
Warren JW, Jian N, Gallicchio L, Wu D, Clauw DJ (2018) Prodrome and non-prodrome phenotypes of bladder pain syndrome/interstitial cystitis. Urol 118:52–58. https://doi.org/10.1016/j.urology.2018.05.004
Quincke HI (1882) Uber akutes umschriebenes Hautoedem. Monat Prakt Dermatol 1:160–169
Bork K (2016) A decade of change: recent developments in pharmacotherapy of Hereditary Angioedema (HAE). Clin Rev Allergy Immunol 51:183–192
Zuraw BL, Christiansen SC (2014) Hereditary angioedema and bradykinin-mediated angioedema. In: Adkinson NF, Bochner BS, Burks AW et al (eds) Middleton’s allergy: principles and practice, 8th edn. Philadelphia, PA, Elsevier Saunders, pp 588–601
Zuraw BL, Christiansen SC (2016) HAE: pathophysiology and underlying mechanisms. Clin Rev Allergy Immunol 51(2):216–229. https://doi.org/10.1007/s12016-016-8561-8
Busse PJ, Christiansen SC (2020) Hereditary angioedema. N Engl J Med 382:1136–1148. https://doi.org/10.1056/NEJMra1808012
Kaplan A (2010) Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol 126:918–925
Kaplan AP, Joseph K (2017) Pathogenesis of hereditary angioedema: the role of the bradykinin-forming cascade. Immunol Allergy Clin N Am 37(3):513–525. https://doi.org/10.1016/j.iac.2017.04.001
Hofman ZLM, Relan A, Zeerleder S, Drouet C, Zuraw B, Hack CE (2016) Angioedema attacks in patients with hereditary angioedema: local manifestations of a systemic activation process. J Allergy Clin Immunol 138:359–366
Bork K, Meng G, Staubach P, Hardt J (2006) Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Amn J Med 119:267–274
Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Wait S et al (2014) Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet J Rare Dis 9:99. https://doi.org/10.1186/1750-1172-9-99
Lumry WR (2013) Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema. Am J Man Care 19:S103–S110
Aygören-Pürsün E, Magerl M, Maetzel A, Maurer M (2018) Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis 13(1):73. https://doi.org/10.1186/s13023-018-0815-5
Donaldson VH, Evans RR (1963) A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C’1-esterase. Am J Med 35:37–44
Crowder JR, Crowder TR (1917) Five generations of angioneurotic edema. Arch Int Med 20:840–852
Dunlap HF, Lemon WS (1929) The hereditary type of angioneurotic edema. Am J Med Sci 177:259–271
Spaulding WB (1955) Hereditary angioneurotic oedema in two families. Can Med Assoc J 73:181–187
Cohen JD (1961) Chronic familial giant urticaria. Ann Int Med 54:331–335
Landerman NS (1962) Hereditary angioneurotic edema. J Allergy 33:316–329
Magerl M, Doumoulakis G, Kalkounou I, Weller K, Church MK, Kreuz W et al (2014) Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema. Clin Exp Derm 39(3):298–303. https://doi.org/10.1111/ced.12285
Rasmussen ER, Valente de Freitas P, Bygum A (2016) Urticaria and prodromal symptoms including erythema marginatum in Danish patients with hereditary angioedema. Acta Derm Venereol 96:373–376
Caballero T, Maurer M, Longhurst HJ, Aberer W, Bouillet L, Fabien V (2016) Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema. J Invest Allergol Clin Immunol 26(6):383–386. https://doi.org/10.18176/jiaci.0102
Farkas H, Harmat G, Fay A, Fekete B, Karádi I, Visy B et al (2001) Erythema marginatum preceding an oedematous attack of hereditary angioneurotic oedema. Acta Derm Venereol 81:376–377. https://doi.org/10.1080/000155501317140188
Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, Frank M et al (2017) International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy 72(2):300–313. https://doi.org/10.1111/all.13001
Leibovich-Nassi I, Golander H, Somech R, Har-Even D, Reshef A (2019) A new instrument for the evaluation of premonitory signs and symptoms (prodromes) of Hereditary Angioedema. Allergy. 74: S106 (P. 215)
Leibovich-Nassi I, Golander H, Somech R, Har-Even D, Reshef A (2019) Are HAE patients able to distinguish prodromes from attacks, and are they correlated? Allergy, Ast Clin Immunol 15(Suppl 4):P10
Longhurst HJ, Carr S, Khair K (2007) C1-inhibitor concentrates home therapy for hereditary angioedema: a viable, effective treatment option. Clin Exp Immunol 147:11–17. https://doi.org/10.1111/j.1365-2249.2006.03256.x
Longhurst HJ, Farkas H, Craig T, Aygören-Pürsün E, Bjorkander BC, J, et al (2010) HAE international home therapy consensus document. Allergy Ast Clin Immunol 6:22. https://doi.org/10.1186/1710-1492-6-22
Murphy E, Donahue C, Omert L, Persons S, Tyma TJ, Chiao J et al (2019) Training patients for self-administration of a new subcutaneous C1-inhibitor concentrate for hereditary angioedema. Nurs Open 6(1):126–135. https://doi.org/10.1002/nop2.194
Wilson D, Bork K, Shea EP, Rentz AM, Blaustein MB, Pullman WE (2010) Economic costs associated with acute attacks and long-term management of hereditary angioedema. Ann Allergy, Ast Immunol 104(4):314–320. https://doi.org/10.1016/j.anai.2010.01.024
Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT (2010) The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Allergy Ast Proc 31(5):407–414
Lumry WR (2018) Hereditary angioedema: the economics of treatment of an orphan disease. Front Med 5:22. https://doi.org/10.3389/fmed.2018.00022
Maurer M, Aberer W, Bouillet L, Caballero T, Fabien V, Kanny G et al (2013) Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS ONE 8(2):e53773. https://doi.org/10.1371/journal.pone.0053773
Kőhalmi KV, Veszeli N, Cervenak L, Varga L, Farkas H (2017) A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum. Immunol Let 189:90–93. https://doi.org/10.1016/j.imlet.2017.05.015
Frank MM, Gelfand JA, Atkinson JP (1976) Hereditary angioedema: the clinical syndrome and its management. Ann Int Med 84:580–593
Donaldson VH, Rosen FS (1966) Hereditary angioneurotic edema: a clinical survey. Pediatrics 6:1017–1027
Beck P, Willis D, Davies GT et al (1973) A family study of hereditary angioneurotic oedema. Quart J Med 42(166):317–339 (PMID:4594447)
Williamson DM (1979) Reticulate erythema a prodrome in hereditary angio-oedema. Br J Dermatol 10:549–552
Starr JC, Brasher GW (1974) Erythema marginatum preceding hereditary angioedema. J Allergy Clin Immunol 53:352–355
Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC (2000) Erythema marginatum. In: Dermatology: Springer Verlag, Berlin-Heidelberg. pp.576–577
Martinez-Saguer I, Farkas H (2016) Erythema marginatum as an early symptom of hereditary angioedema: case report of 2 newborns. Pediatrics 137(2):e20152411. https://doi.org/10.1542/peds
Starr JC, Brasher GW, Rao A, Posey D (2004) Erythema marginatum and hereditary angioedema. South Med J 97(10):948–950 (PMID:15558919)
Bygum A, Broesby-Olsen S (2011) Rapid resolution of erythema marginatum after icatibant in acquired angioedema. Acta Derm Venereol 91:185–186
Ali MA, Borum ML (2014) Hereditary angioedema: what the gastroenterologist needs to know. Clin Exp Gastroenterol 20(7):435–445. https://doi.org/10.2147/CEG.S50465
Hahn J, Hoess A, Friedrich DT, Mayer B, Schauf L, Hoffman TK et al (2018) Unnecessary abdominal interventions in patients with hereditary angioedema. J Deutsch Dermatol Gessel 16(12):1443–1449. https://doi.org/10.1111/ddg.13698
Nielsen EW, Gran JT, Straume B, Mellbye OJ, Johansen HT, Mollnes TE (1996) Hereditary angio-edema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Int Med 23:119–130
Dennehy JJ (1970) Report of a large kindred with defect in C1 esterase inhibitor and review of the literature. Ann Int Med 73:55–59
Leibovich-Nassi I, Reshef A, Somech R, Golander H (2017) A survey of hereditary angioedema in Israel. Allergy, Ast Clin Immunol 13(Suppl 2):34
Bouillet L, Launay D, Fain O, Boccon-Gibod I, Laurent J, Martin L et al (2013) Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. Ann Allergy Ast Immunol 111:290–294. https://doi.org/10.1016/j.anai.2013.07.012
Ohela K (1977) Hereditary angioneurotic oedema in Finland. Acta Med Scand 201:415–427
Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A et al (1982) Hereditary angioedema: An appraisal of 104 cases. Am J Med Sci 284:2–9
Manolis AJ, Marketou ME, Gavras I, Gavras H (2010) Cardioprotective properties of bradykinin: role of the B(2) receptor. Hypertens Res 33:772–777. https://doi.org/10.1038/hr.2010.82
Long AT, Kenne E, Jung R, Fuchs TA, Renné T (2016) Contact system revisited: an interface between inflammation, coagulation, and innate immunity. J Thromb Haemost 14:427–437
Bönner G, Preis S, Schunk U, Toussaint C, Kaufmann W (1990) Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J Cardiovasc Pharmacol 15(Suppl 6):S46-56
Magerl M, Bader M, Gompel A, Joseph K, Kaplan AP, Kojda G et al (2014) Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012. Inflamm Res 63:173–178. https://doi.org/10.1007/s00011-013-0693-1
Mathivanan S, Devesa I, Changeux JP, Ferrer-Montiel A (2016) Bradykinin Induces TRPV1 exocytotic recruitment in peptidergic nociceptors. Front Pharmacol 7:178. https://doi.org/10.3389/fphar.2016.00178
Kádková A1, Synytsya V, Krusek J, Zímová L, Vlachová V (2017) Molecular basis of TRPA1 regulation in nociceptive neurons. A review. Physiol Res. 18;66(3):425–439
Grace M, Birrell MA, Dubuis E, Maher SA, Belvisi MG (2012) Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin. Thorax 67(10):891–900. https://doi.org/10.1136/thoraxjnl-2011-201443
Al-Shamlan F, El-Hashim AZ (2019) Bradykinin sensitizes the cough reflex via a B2 receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase. Respir Res 20(1):110. https://doi.org/10.1186/s12931-019-1060-8
Luyasu S, Charignon D, Ponard D, Drouet C, Ghannam A (2018) Angioedema: systemic activation process during prodromes. Ann Allergy Ast Immunol 121(2):248–249. https://doi.org/10.1016/j.anai.2018.04.026
Wu MA, Bova M, Berra S, Senter R, Parolin D, Caccia S et al (2020) The central role of endothelium in hereditary angioedema due to C1 inhibitor deficiency. Int Immunopharmacol 82:106304. https://doi.org/10.1016/j.intimp.2020.106304
Kajdacsi E, Jani PK, Csuka D, Varga L, Prohaszka Z, Farkas H (2014) Endothelial cell activation during edematous attacks of hereditary angioedema types I and II. J Allergy Clin Immunol 133:1686–1691
Millán J, Robert J, Cain RJ, Reglero-Real N, Bigarella C, Marcos-Ramiro B, et al (2010) Adherens junctions connect stress fibers between adjacent endothelial cells. BMC Biol. 8:11. http://www.biomedcentral.com/1741-7007/8/11
Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S et al (2012) Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Comm 3:1208. https://doi.org/10.1038/ncomms2199
Dejana E, Orsenigo F (2013) Endothelial adherens junctions at a glance. J Cell Sci 126:2545–2549. https://doi.org/10.1242/jcs.124529
Oschatz C, Maas C, Lecher B, Jansen T, Björkqvist J, Tradler T et al (2011) Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity 34(2):258–268. https://doi.org/10.1016/j.immuni.2011.02.008
Maurer M, Church MK (2012) Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistamines. Exp Dermatol 21(2):154–155. https://doi.org/10.1111/j.1600-0625.2011.01410.x
Fadel R, Ramboer I, Chatterjee N, Rihoux JP, Derde MP (2000) Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects. Allergy 55(4):382–385
Veszeli N, Kőhalmi KV, Kajdácsi E, Gulyás D, Temesszentandrási G, Cervenak L et al (2018) Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack. Allergy 73(2):516–520. https://doi.org/10.1111/all.13327
Kőhalmi KV, Mező B, Veszeli N, Benedek S, Fehér A, Holdonner A et al (2020) Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema. Int Immunopharmacol 81:106293. https://doi.org/10.1016/j.intimp.2020.106293
Myles PS, Urquhart N (2005) The linearity of the visual analogue scale in patients with severe acute pain. Anaest Intens Care 33(1):54–58
Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A et al (2010) Recommendations for assessing patient reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 65(3):290–295. https://doi.org/10.1111/j.1398-9995.2009.02263.x
Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ, Brzoza Z, Canonica GW et al (2011) Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 66(7):840–844. https://doi.org/10.1111/j.1398-9995.2011.02580.x
Vernon MK, Rentz AM, Wyrwich KW, ֶWhite MV, ֶGrienenberger A, (2009) Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema. Qual Life Res 18:929–939. https://doi.org/10.1007/s11136-009-9509-8
McMillan CV, Speight J, Relan A, Bellizi L, Haase G, Cicardi M (2012) Content validity of visual analog scales to assess symptom of acute angioedema attacks in adults with hereditary angioedema: an interview study. Patient 5(2):113–126. https://doi.org/10.2165/11597490-000000000-00000
Bonner N, Abetz-Webb L, Renault L, Caballero T, Longhurst H, Maurer M et al (2015) Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies. Health Qual Life Outcomes 13:92. https://doi.org/10.1186/s12955-015-0292-7
Leibovich-Nassi I, Reshef A, Somech R, Har-Even D, Golander H (2020) Prodromes can predict oncoming attacks of hereditary angioedema. Submitted to the EAACI Digital Congress, London
Barlow JH, Cullen A, Rowe IF (1999) Comparison of knowledge and psychological well-being between patients with a short disease duration and patients with more established rheumatoid arthritis. Pat Edu Counsel 38:195–203
Scully JL (2004) What is a disease? Disease, disability and their definitions. Europ Moll Biology Organ Rep 5(7):650–653
Folkman S, Lazarus R (1980) An analysis of coping in a middle-aged community sample. J Health Soc Behav 21:219–239
Lazarus R, Folkman S (1984) Stress. appraisal and coping, New York, Springer
Maurer M, Magerl M, Ansotegui I, Aygören-Pürsün E, Betschel S, Bork K et al (2018) The international WAO/EAACI guideline for the management of hereditary angioedema—the 2017 revision and update. Allergy 73(8):1575–1596. https://doi.org/10.1111/all.13384
Betschel S, Badiou J, Binkley K, Borici-Mazi R, Hebert J, Kanani A et al (2019) The International/ Canadian Hereditary Angioedema Guideline. Allergy Ast Clin Immunol 15:72. https://doi.org/10.1186/s13223-019-0376-8
deShazo RD, Frank MM (2010) Genius at work: Osler’s 1888 article on hereditary angioedema. Am J Med Sci 339:179–181. https://doi.org/10.1097/MAJ.0b013e3181b28028
Warsh CK, Sir William Osler 1849–1919 (2018) Voices Royal Soc Canada. https://rsc-src.ca/en/voices/sir-william-osler-1849-1919
Funding
ILN received educational grants from the Stanley Steyer Foundation (Tel Aviv University, Israel) and CSL-Behring (Germany).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethics Approval
The study was approved and supervised by the Ethics and Helsinki IRB committees of Tel Aviv University, Sheba Medical Center and Barzilai Medical Center, Israel.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Leibovich-Nassi, I., Reshef, A. The Enigma of Prodromes in Hereditary Angioedema (HAE). Clinic Rev Allerg Immunol 61, 15–28 (2021). https://doi.org/10.1007/s12016-021-08839-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-021-08839-4